Key takeaways
- Mysimba contains naltrexone and bupropion and acts on pathways involved in appetite; Xenical contains orlistat and reduces dietary fat absorption. Mysimba and Xenical assessments.
- Both have evidence for weight management alongside dietary and activity support, but neither guarantees a particular loss. EMA evidence summaries.
- Opioid use is a major safety issue with Mysimba. EMA opioid advice.
- Orlistat’s bowel effects do not mean it has no other risks or interactions. Xenical product information.
Choosing between these medicines starts with your medical history, not a ranking of which causes the most weight loss. For one person, an opioid pain medicine may rule out Mysimba. For another, bowel symptoms may make orlistat difficult to sustain.
These are different treatments, not brand and generic versions of the same product.
How do Mysimba and Xenical differ?
Mysimba influences appetite-related pathways; Xenical reduces the absorption of some fat from food.
| Question | Mysimba | Xenical |
|---|---|---|
| Active ingredient | Naltrexone plus bupropion | Orlistat |
| Main treatment effect | Acts on appetite and food-intake pathways | Acts on fat-digesting enzymes in the gut |
| Common tolerability issue | Nausea, vomiting or constipation | Oily stools, leakage or urgency |
| Key discussion before treatment | Opioids, blood pressure and seizure history | Bowel or liver conditions and medicine interactions |
The EMA assessments describe benefits alongside reduced-calorie diets and support. They do not justify labels such as “for emotional eaters” or “for people who lack discipline”. Those descriptions oversimplify both eating behaviour and treatment.
Which produces more weight loss?
Separate trial averages cannot reliably predict which medicine will work better for you.
Studies differ in participants, follow-up, dietary support and how they count people who leave treatment. Total weight lost is also different from weight lost beyond the placebo group’s result. Mixing those figures makes comparisons look more decisive than they are.
Ask the prescriber what counts as a worthwhile response and when treatment will be reassessed. The EMA summaries specify response checkpoints for both medicines. The point of a checkpoint is to avoid continuing something that is not providing enough benefit. Mysimba assessment, Xenical assessment.
Why are opioids important with Mysimba?
Naltrexone can interfere with opioid treatment, so pain medicines and planned surgery must be discussed before prescribing.
This includes medicines you may know by a brand rather than by the word opioid. Bring the names of painkillers, cough remedies and treatments for opioid dependence. Do not try to overcome opioid blockade by taking more pain medicine. EMA opioid advice.
The EMA’s review also calls for regular reassessment of cardiovascular risk. Long-term cardiovascular safety remains an area of uncertainty; continued treatment should not become an automatic repeat prescription. Mysimba referral and safety measures.
A seizure history, uncontrolled high blood pressure and certain psychiatric conditions can also make Mysimba unsuitable. A full medication and health review is more useful than choosing it simply because you prefer a tablet.
What makes the decision practical in South Africa?
Compare the complete treatment plan, including follow-up and tolerability, rather than the medicine price alone.
Ask how reviews will be arranged, what the likely ongoing cost is and what you should do if you cannot obtain the next pack. Confirm the prescribed product and its local supply requirements. The European approvals cited here provide useful evidence; they do not establish the registration or stock position of a particular South African pack.
If you are considering semaglutide instead, read the Rybelsus guide. It explains why a diabetes tablet is not an automatic replacement for an injectable weight-management medicine.
Do and don’t
Do:
- Bring a complete medicine list, including occasional pain relief.
- Agree on a response checkpoint and a plan for troublesome side effects.
Don’t:
- Combine weight-loss medicines without a prescriber’s plan.
- Treat average trial weight loss as a promise or a judgement about effort.
